Shuttle Pharmaceuticals Holdings, Inc. (SHPH) · Nov 6, 2026 · Auditor change

Shuttle Pharmaceuticals auditor change completes after control warnings

Auditor change — Bush & Associates engaged November 2, 2026

Shuttle Pharmaceuticals completes its auditor change, but the filing adds no evidence that its material control weaknesses are fixed.

Shuttle is a small, early-stage company trying to build an AI-driven molecular-discovery platform while also pursuing a newer digital-infrastructure strategy through United Dogecoin. Its prior auditor dismissal was already disclosed, alongside material weaknesses in financial reporting controls and limited technical accounting expertise.

The successor appointment closes an open administrative gap, not the underlying accounting problem. Bush & Associates was formally engaged on November 2 to audit the year ending December 31, 2026 and review the three 2027 interim quarters. 〔0〕 This is a necessary step after the previously announced dismissal, but the filing does not say that the existing control weaknesses have been remediated.

The clean handoff language removes one possible source of friction, but does not create a new business catalyst. The company says the new firm had no prior consultations involving accounting opinions, disagreements, or reportable events. 〔1〕 That makes the change look procedural rather than evidence of a newly resolved dispute; the more important test remains whether Shuttle can produce timely, reliable filings while financing and executing its broader strategy.

Bottom line: This is an expected follow-through on a previously announced auditor switch. It keeps the reporting process moving, but does not materially change Shuttle’s underlying control, funding, or execution story.

What to watch next

FY 2026 audit and Form 10-K filing

Original filing on SEC EDGAR

More Shuttle Pharmaceuticals Holdings, Inc. news

Shuttle Pharmaceuticals auditor change completes after control warnings | SHPH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.